types of glp-1 receptor agonists Table 1 from Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Glucagon-like peptide 1(GLP-1) receptor agonists
Description
Despite their exploding popularity, the current GLP-1 injections (semaglutide though is also orally available) face accessibility issues due to cost and adverse effects and thus the next big move for the space, an easy to - pop pill could be lucrative, for which clinical trials are already well underway

GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity

The clinical data is real

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

FDA is acknowledging that the drugs dont have the same risk seen with older weight-loss medicines
